VS

Vitaspring Biomedical Co. LtdOOTC VSBC Stock Report

Last reporting period 31 Oct, 2022

Updated 11 Nov, 2024

Last price

Market cap $B

3.304

Middle

Exchange

OOTC - OTC

VSBC Stock Analysis

VS

Uncovered

Vitaspring Biomedical Co. Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

3.304

Dividend yield

Shares outstanding

206.52 B

VitaSpring Biomedical Co. Ltd. engages in the research and development of stem cell applications in regenerative medicine and the establishment of advanced medical research centers and high standard cell production centers. The company is headquartered in Irvine, California and currently employs 0 full-time employees. The company went IPO on 2019-10-01. The firm is engaged in the business of developing and marketing products that promote wellness and a healthy lifestyle. The firm invests in research and development of stem cell applications in regenerative medicine, establish advanced medical research centers and cell production centers and provides GTP standard stem cell preparations for the development of cellular drugs. The firm is focused on the fields of medicine, preventive health care, beauty, and anti-aging. The company is also focused on developing X.MSC cytopharmaceuticals.

View Section: Eyestock Rating